Invenomic Capital Management LP Sells 571,219 Shares of CoreCivic, Inc. (NYSE:CXW)

Invenomic Capital Management LP decreased its position in CoreCivic, Inc. (NYSE:CXW - Free Report) by 55.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 454,831 shares of the real estate investment trust's stock after selling 571,219 shares during the period. Invenomic Capital Management LP owned about 0.41% of CoreCivic worth $9,888,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Meeder Asset Management Inc. bought a new stake in CoreCivic in the 4th quarter worth $43,000. Smartleaf Asset Management LLC grew its stake in shares of CoreCivic by 318.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,442 shares of the real estate investment trust's stock worth $53,000 after purchasing an additional 1,859 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in CoreCivic by 86,300.0% during the 4th quarter. Russell Investments Group Ltd. now owns 4,320 shares of the real estate investment trust's stock valued at $94,000 after purchasing an additional 4,315 shares during the period. GAMMA Investing LLC increased its holdings in CoreCivic by 25.5% during the 4th quarter. GAMMA Investing LLC now owns 4,686 shares of the real estate investment trust's stock valued at $102,000 after purchasing an additional 953 shares during the period. Finally, KBC Group NV raised its position in CoreCivic by 57.3% during the 4th quarter. KBC Group NV now owns 5,477 shares of the real estate investment trust's stock valued at $119,000 after purchasing an additional 1,995 shares during the last quarter. 85.13% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have recently issued reports on CXW shares. StockNews.com raised CoreCivic from a "hold" rating to a "buy" rating in a research note on Wednesday. Wedbush reiterated an "outperform" rating and issued a $30.00 price target on shares of CoreCivic in a report on Tuesday, February 11th. Finally, Noble Financial upgraded shares of CoreCivic from a "market perform" rating to an "outperform" rating in a report on Wednesday, February 12th.

CoreCivic Price Performance

CXW opened at $21.88 on Friday. CoreCivic, Inc. has a 12-month low of $10.74 and a 12-month high of $24.99. The company has a market cap of $2.39 billion, a price-to-earnings ratio of 35.87 and a beta of 0.79. The company has a current ratio of 1.57, a quick ratio of 1.51 and a debt-to-equity ratio of 0.65. The stock has a fifty day simple moving average of $20.89 and a two-hundred day simple moving average of $20.49.

CoreCivic (NYSE:CXW - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.10. The company had revenue of $488.60 million during the quarter, compared to analyst estimates of $478.49 million. CoreCivic had a net margin of 3.51% and a return on equity of 5.97%. CoreCivic's quarterly revenue was down 2.4% compared to the same quarter last year. During the same period last year, the business earned $0.46 EPS. Research analysts predict that CoreCivic, Inc. will post 1.5 earnings per share for the current fiscal year.

CoreCivic Company Profile

CoreCivic, Inc owns and operates partnership correctional, detention, and residential reentry facilities in the United States. It operates through three segments: CoreCivic Safety, CoreCivic Community, and CoreCivic Properties. The company provides a range of solutions to government partners that serve the public good through corrections and detention management, a network of residential reentry centers to help address America's recidivism crisis, and government real estate solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.